This news of Ozempic price cuts comes on the heels, or tablet, of Novo Nordisk developing a weight loss pill that mirrors the ...

Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...

Senator Bernie Sanders (I-Vt.) once again ramped up pressure on weight loss drugmakers, announcing that he received ...

Novo Nordisk is under pressure over US drug prices as CEO Lars Fruergaard Jørgensen prepares to testify before the Senate ...

The European Medicines Agency backed the use of Novo Nordisk's Wegovy in patients with an obesity-related heart condition, ...

Marcus Remmers, a partner of the Planetary Health Investments team of Novo Holdings, the controlling shareholder of Novo ...

Novo Nordisk touted more data for its oral amycretin, noting that subjects had not reached a plateau in their weight loss at ...

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Cambridge, USA-based Korro Bio has entered a collaboration with Denmark’s Novo Nordisk to advance the discovery and ...

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...

Novo Nordisk exercises option to license Kallyope-identified ligand for therapeutic development including potential treatment for obesity ...

The global insulin pens market is experiencing rapid expansion, driven by the rising global prevalence of diabetes. According ...